AstraZeneca Suspends Coronavirus Vaccine Trial, Raising Doubts Reduces Actions
AstraZeneca has suspended global trials of its investigational coronavirus vaccine after an unexplained illness in one participant, starting moves at the UK drugmaker on Wednesday as the move noted a decline in customers for early rollout. AstraZeneca said Tuesday that it had voluntarily suspended the tests.
AstraZeneca Suspends Coronavirus Vaccine Trial, Raising Doubts Reduces Actions Read More »